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Commentary: matched cohorts can be useful
Stephen Evans
Most BMJ readers are familiar with matched case›
control studies but fewer will be familiar with matched
cohort studies. Case›control studies are based on
selecting cases of a disease and then finding people
who are as similar as possible to the cases. The study by
Helms et al is not a case›control study; people were
selected not on the basis of having, or not having, the
outcome of interest (in this instance mortality) but on
the basis of being exposed or not to something that
may affect mortality.
Matched cohort studies have been published in the
BMJ before—for example, a study examining air bags
and deaths of car drivers.1 Helms et al have used simi›
lar methods with Danish national data to look at
Salmonella (reference 19 of their paper). A common
feature of these studies is the existence of a large data›
base in which the individuals who are exposed (to bac›
terial infection or air bags) can be compared with
similar unexposed people. Helms et al used record
linkage between databases, obtaining data from micro›
biology laboratories to define exposed patients and
using the national Danish civil registration system to
obtain unexposed people from the general population.
They also used the registration system to obtain
outcome data on subsequent mortality for exposed
and unexposed people and two further databases to
determine possible confounding from hospital admis›
sions for diseases other than bacterial infection.
The main method of analysis for cohort studies is
to use the time taken to an event that is the outcome
under study, a survival analysis. The outcome is usually
death, but it could be another event such as diagnosis
of myocardial infarction or cancer. Cohort studies usu›
ally have to be very large to obtain a sufficient number
of outcome events. This may make their costs prohibi›
tive, but with electronic databases the costs can be
greatly reduced. Similarly, the costs of carrying out
matching in cohort studies have restricted their use.
Matching prevents the possible association between
the matching factors and the exposure at the start of
the study, although not necessarily associations occur›
ring as an observational study progresses. Matching
should be taken into account in the (conditional)
analysis, as has been done by Helms et al.2
Matching may not increase statistical power
(efficiency) but it does not introduce bias (as it does in
case›control studies).3 With large databases any small
loss in efficiency may be unimportant, and the
convincing power to the reader of the similarity of the
exposed and unexposed cohorts at the start is a gain.
What factors should be used for matching? Helms
et al used age, sex, and county of residence. They have
used a 1:10 exposed:unexposed ratio. They have also
adjusted the survival analysis for comorbidity, based on
eight different diagnostic groups. It is possible to match
for morbidity or other risk factors, but it would make
matching difficult and may not offer any gains. An
alternative, used particularly in drug safety, is to match
on a “propensity” score.4 This score measures the like›
lihood of being given the treatment rather than the
likelihood of having the outcome. The purpose is to
reduce confounding in either the design or the analy›
sis so that comparisons are valid.
Scandinavia has better national databases than
elsewhere, but the United Kingdom has good
databases based on general practitioners’ computer
records. The potential of these is considerable, and
matched cohort designs could be used more often.
Concerns over confidentiality of records may make this
difficult, but it is to be hoped that good epidemiology is
not going to be stopped because of misguided ethicists
and lawyers.5
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